Morphea after initiation of dupilumab in two pediatric atopic dermatitis patients

被引：2

作者：

Wang, Sonia ^{[1
,4
]}

Berry, Corbett T. ^{[2
]}

Treat, James R. ^{[2
,3
]}

Jen, Melinda ^{[2
,3
]}

机构：

[1] Univ Penn, Perelman Sch Med, Philadelphia, PA USA

[2] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA USA

[3] Childrens Hosp Philadelphia, Sect Pediat Dermatol, Philadelphia, PA USA

[4] Univ Penn, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA

来源：

PEDIATRIC DERMATOLOGY | 2023年 / 40卷 / 03期

关键词：

atopic dermatitis; drug-related side effects and adverse reactions; localized scleroderma; Th1-Th2; balance; LOCALIZED SCLERODERMA; PROFILES; CYTOKINE; BLOOD; CELLS;

D O I：

10.1111/pde.15200

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Morphea is a rare multifactorial autoimmune disorder characterized by a complex and dynamic interplay between Th1 and Th2 signaling. Active clinical trials are currently investigating the safety and efficacy of dupilumab for the treatment of primary morphea. Here, we present two cases of morphea that developed in pediatric atopic dermatitis patients treated with dupilumab. These findings may support a causal relationship between IL-4 receptor blockade and the development of the early inflammatory phase of morphea.

引用

页码：540 / 543

页数：4

共 50 条

[31] Dupilumab for the treatment of atopic dermatitis
不详
PEDIATRIC DERMATOLOGY, 2021, 38 (06) : E643 - E644
[32] Dupilumab for the Treatment of Atopic Dermatitis
Ferreira, S.
Torres, T.
ACTAS DERMO-SIFILIOGRAFICAS, 2018, 109 (03): : 230 - 240
[33] A retrospective review of dupilumab for atopic dermatitis patients with allergic contact dermatitis
Chipalkatti, Naina
Lee, Nicole
Zancanaro, Pedro
Dumont, Nicole
Kachuk, Courtney
Rosmarin, David
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (04) : 1166 - 1167
[34] The use of dupilumab in atopic dermatitis
Heratizadeh, A.
Werfel, T.
ALLERGOLOGIE, 2019, 42 (06) : 258 - 265
[35] Effectiveness of dupilumab in atopic dermatitis
Romero Puerto, J.
Garcia Marin, J.
Fages Perez, M.
Martinez-Echevarria Gil-Delgado, Z.
Moreno Herrera, A.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1555 - 1555
[36] Severe atopic dermatitis and dupilumab
Bernardo, Wanderley
Bernardo, Luca Silveira
Baroni, Juliana Hegedus
Simoes, Ricardo dos Santos
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (01): : 2 - 6
[37] The use of dupilumab in atopic dermatitis
Heratizadeh, A.
Werfel, T.
DERMATOLOGIE IN BERUF UND UMWELT, 2020, 68 (01) : 27 - 34
[38] Dupilumab nonresponders in atopic dermatitis
Leung, Donald Y. M.
Ong, Peck Y.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 (03) : 267 - 268
[39] Dupilumab-associated psoriasis and psoriasiform dermatitis in patients with atopic dermatitis
Casale, Fiore
Nguyen, Cristina
Dobry, Allison
Smith, Janellen
Mesinkovska, Natasha Atanaskova
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (03) : 394 - 397
[40] Dupilumab for atopic dermatitis: what are patients learning on YouTube?
Pithadia, Deeti J.
Reynolds, Kelly A.
Lee, Erica B.
Wu, Jashin J.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (01) : 571 - 572

← 1 2 3 4 5 →